# Beta-Sitosterol

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/beta-sitosterol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Other
**Also Known As:** β-Sitosterol, 22,23-Dihydrostigmasterol, 24α-Ethylcholesterol, Plant sterol, Phytosterol, Stigmast-5-en-3β-ol, BSS

## Overview

Beta-sitosterol is a plant-derived phytosterol that structurally resembles cholesterol and competitively inhibits its intestinal absorption by displacing it from mixed micelles. It is most clinically recognized for reducing benign prostatic hyperplasia (BPH) symptoms by modulating 5-alpha-reductase activity and reducing prostatic [inflammation](/ingredients/condition/inflammation) via inhibition of arachidonic acid [metabolism](/ingredients/condition/weight-management).

## Health Benefits

• Reduces BPH symptoms: Strong evidence from multiple RCTs showing improvements in IPSS scores (5.4-7.4 point reduction), urinary flow (4.5 mL/s increase), and post-void residual volume (33.5-35.4 mL decrease) (PMID: 9313662, 7540705)
• Improves urinary function: Meta-analysis of 4 RCTs (519 men) confirmed significant improvements in urinary symptoms and flow rates with nonglucosidic beta-sitosterol (PMID: 10368239)
• Maintains long-term prostate health: 18-month extension study showed sustained benefits in men continuing beta-sitosterol treatment (PMID: 10792163)
• May support healthy cholesterol levels: Competes with cholesterol for intestinal absorption via NPC1L1, modestly lowering serum cholesterol (mechanism established, clinical significance varies)
• Potential anti-cancer properties: Preclinical evidence suggests pro-apoptotic effects in prostate cells via caspase activation and PI3K/Akt inhibition, though large human RCTs are lacking (PMID: 38148931)

## Mechanism of Action

Beta-sitosterol reduces intestinal cholesterol absorption by competing with cholesterol for incorporation into bile acid micelles, thereby limiting cholesterol uptake via the NPC1L1 transporter in enterocytes. In prostatic tissue, it inhibits 5-alpha-reductase, reducing conversion of [testosterone](/ingredients/condition/hormonal) to dihydrotestosterone (DHT), and suppresses arachidonic acid [metabolism](/ingredients/condition/weight-management) by inhibiting cyclooxygenase and lipoxygenase enzymes, reducing [prostaglandin](/ingredients/condition/inflammation)-driven prostatic inflammation. It also modulates SHBG binding affinity and may influence apoptotic pathways via downregulation of NF-κB signaling in prostate cells.

## Clinical Summary

A meta-analysis of 4 randomized controlled trials involving 519 men demonstrated that beta-sitosterol supplementation significantly improved International Prostate Symptom Scores (IPSS) by 5.4–7.4 points, increased peak urinary flow rate by approximately 4.5 mL/s, and decreased post-void residual volume by 33.5–35.4 mL compared to placebo (PMIDs: 9313662, 7540705). Evidence for cholesterol reduction is moderate, with meta-analyses showing LDL reductions of approximately 8–10% at doses of 1.5–3 g/day of plant sterols, though beta-sitosterol as an isolated compound has fewer dedicated trials than combined phytosterol mixtures. The overall evidence base for BPH symptom relief is considered strong given consistent RCT outcomes, while [cardiovascular](/ingredients/condition/heart-health) lipid data relies more heavily on broader plant sterol literature. Long-term efficacy and safety data beyond 6 months remain limited for isolated beta-sitosterol supplementation.

## Nutritional Profile

Beta-Sitosterol is a bioactive phytosterol (plant sterol), not a macronutrient source. It is not consumed as a food in isolation but as a concentrated supplement or naturally occurring compound in plant-based foods. Key compositional details: Primary compound: Beta-sitosterol (a 4-desmethyl sterol, C29H50O, MW 414.7 g/mol), structurally similar to cholesterol with an ethyl group at C-24. Natural food concentrations: Vegetable oils (soybean oil ~325 mg/100g, corn oil ~952 mg/100g, olive oil ~150-200 mg/100g), nuts (almonds ~78 mg/100g, peanuts ~61 mg/100g), seeds (pumpkin seeds ~265 mg/100g), avocado (~76 mg/100g), whole grains (~40-80 mg/100g). Supplement doses studied in RCTs: 20-130 mg/day of nonglucosidic beta-sitosterol (free sterol form), with most BPH studies using 60-195 mg/day total phytosterols. Bioavailability: Poorly absorbed — intestinal absorption rate is only 4-7% compared to ~50% for dietary cholesterol, due to active efflux by ABCG5/ABCG8 transporters. Absorption is enhanced in lipid-rich matrices and reduced by competing phytosterols. The free (nonglucosidic) form shows superior bioavailability versus glycoside-conjugated forms. No significant caloric contribution at therapeutic doses. Contains no protein, carbohydrates, or fiber as a pure compound. Co-occurring compounds in whole food sources include other phytosterols (campesterol, stigmasterol), tocopherols, and fatty acids.

## Dosage & Preparation

Clinically studied doses for BPH: 60-130 mg/day free beta-sitosterol or standardized phytosterol mixtures, typically taken as 20mg three times daily or 130mg once daily. Glucosidic forms at 0.3 mg/day showed mixed results. Up to 3g/day tolerated short-term, but long-term doses above 800mg/day may lower carotenoid levels. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Beta-sitosterol is generally well tolerated, with the most commonly reported side effects being mild gastrointestinal symptoms including nausea, in[digestion](/ingredients/condition/gut-health), and diarrhea occurring in a small percentage of users. Individuals with sitosterolemia, a rare autosomal recessive disorder of phytosterol [metabolism](/ingredients/condition/weight-management), must avoid beta-sitosterol entirely due to risk of [cardiovascular](/ingredients/condition/heart-health) complications from excessive sterol accumulation. Beta-sitosterol may reduce the absorption of fat-soluble vitamins (A, D, E, K) and carotenoids when consumed at therapeutic doses, and it can have additive effects with cholesterol-lowering medications such as statins and ezetimibe. Safety has not been established in pregnancy or lactation, and use in these populations should be avoided without medical supervision.

## Scientific Research

Multiple randomized, double-blind, placebo-controlled trials support beta-sitosterol's efficacy for BPH, including a 177-patient study showing 130mg daily improved symptoms significantly over placebo (PMID: 9313662), and a 200-patient trial demonstrating benefits with 60mg daily (PMID: 7540705). A meta-analysis of 4 RCTs involving 519 men confirmed these benefits for nonglucosidic forms (PMID: 10368239).

## Historical & Cultural Context

Beta-sitosterol has been used for centuries in European phytotherapy and Ayurveda for urinary and prostate issues, with saw palmetto extracts containing beta-sitosterol used for BPH-like symptoms since the 1700s. Native American and African traditional medicine utilized plants like Pygeum africanum (rich in sitosterol) for urinary obstruction, with formal documentation in German Commission E monographs since the 1950s.

## Synergistic Combinations

Saw Palmetto, Pygeum africanum, Zinc, Lycopene, Selenium

## Frequently Asked Questions

### How much beta-sitosterol should I take for BPH symptoms?

Clinical trials demonstrating improvements in BPH symptoms have used doses ranging from 60 to 130 mg of pure beta-sitosterol per day, often divided into two or three doses. The pivotal RCTs showing a 5.4–7.4 point reduction in IPSS scores used 20 mg of beta-sitosterol three times daily (60 mg/day total), suggesting this dose range is both effective and well tolerated for urinary symptom relief.

### Does beta-sitosterol actually lower cholesterol?

Yes, beta-sitosterol and related plant sterols reduce LDL cholesterol by approximately 8–10% at doses of 1.5–3 g/day by competitively inhibiting cholesterol absorption in the gut via displacement from bile acid micelles. However, most evidence comes from trials using mixed phytosterol blends rather than isolated beta-sitosterol, and its effect is additive to statin therapy rather than a standalone replacement for lipid-lowering drugs.

### Is beta-sitosterol safe for long-term use?

Most clinical trials supporting beta-sitosterol's efficacy have durations of 3–6 months, and long-term safety data beyond this window for isolated supplementation is limited. It is contraindicated in individuals with sitosterolemia, and at high doses used for cholesterol lowering (1.5–3 g/day), chronic use may impair absorption of fat-soluble vitamins including vitamin E and beta-carotene, so periodic monitoring of micronutrient status is advisable.

### Can beta-sitosterol interact with medications?

Beta-sitosterol can have additive cholesterol-lowering effects when combined with statins (e.g., atorvastatin, rosuvastatin) or ezetimibe, which may be beneficial but warrants physician oversight to avoid excessive LDL reduction. It may also reduce absorption of fat-soluble drugs or supplements if taken simultaneously, and there is theoretical concern about additive effects with other 5-alpha-reductase inhibitors such as finasteride or dutasteride used for BPH or hair loss.

### What is the difference between beta-sitosterol and saw palmetto for prostate health?

Beta-sitosterol is a specific phytosterol compound found in many plants including saw palmetto berries, and it is thought to be one of saw palmetto's active constituents contributing to BPH relief alongside fatty acids like oleic and lauric acid. Isolated beta-sitosterol has demonstrated stronger and more consistent RCT evidence for improving IPSS scores and urinary flow metrics than saw palmetto extracts, which showed no significant benefit over placebo in large NIH-funded trials such as the STEP study (N=225).

### What are the best food sources of beta-sitosterol?

Beta-sitosterol is naturally found in plant-based foods including nuts (especially pistachios and almonds), seeds (pumpkin and sunflower), vegetable oils (corn and soybean oil), and whole grains. However, dietary amounts typically range from 160–400 mg per day, which is below the 1.3–3.2 g doses used in clinical studies for BPH symptom relief. Fortified foods like plant-based margarines and functional foods can provide supplemental amounts, though supplements remain the most reliable way to achieve therapeutic dosages.

### Is beta-sitosterol effective for women's health concerns?

While beta-sitosterol is extensively studied for male prostate and urinary health, evidence in women is limited and primarily focuses on cholesterol management rather than gender-specific health outcomes. Most clinical trials showing symptom improvement have enrolled men with BPH, so its effectiveness for women's specific health concerns remains unclear. Women interested in beta-sitosterol primarily benefit from its potential cholesterol-lowering effects, which are documented across both sexes.

### How does the glucosidic versus non-glucosidic form of beta-sitosterol affect efficacy?

Non-glucosidic beta-sitosterol (free form) is generally considered more bioavailable and effective than glucosidic forms, as it does not require enzymatic breakdown in the digestive tract for absorption. Meta-analyses of BPH trials have primarily demonstrated efficacy with non-glucosidic preparations, making this form the preferred choice for therapeutic outcomes. Most commercial supplements and clinical study formulations use the non-glucosidic form to ensure consistent bioavailability and clinical results.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*